Recent posts

TypePostAuthorRepliesLast updated
Blog entryLetter from 56 non-profits and experts to Secretary of State John Kerry on pressure on global access to medicines initiatives Zack Struver02 days 20 hours ago
Blog entryHuman Rights Council adopts watershed resolution on Access to Medicines thiru05 days 2 hours ago
Blog entryRoger Bate: Eclectic booster of corporate views thiru01 week 1 day ago
Blog entrySeptember 2004: TACD's Future of WIPO Conference thiru01 week 2 days ago
Blog entryFrancis Gurry appoints Sylvie Forbin, lobbyist for Vivendi, as new head of copyright at WIPO James Love01 week 2 days ago
Page2016: KEI comments on NIH proposal for exclusive licenses to Chimeron Bio Corporation Diane Singhroy01 week 3 days ago
Blog entryGates Foundation v. Teachscape: Restrictions on Patenting of Gates-Funded Inventions Andrew Goldman01 week 3 days ago
PageAndrew S. Goldman, Counsel, Policy and Legal Affairs Claire Cassedy02 weeks 1 day ago
Blog entry2016: KEI/MSF comments to NIH on licensing of patents on Attenuated Respiratory Syncytial Virus (RSV) Vaccines James Love02 weeks 2 days ago
Blog entrySCP 24 - A fruitful discussion? Staff02 weeks 2 days ago
Blog entryWIPO Marrakesh Treaty for the blind to come into force September 30, 2016, following ratification by Canada James Love02 weeks 2 days ago
Book pageKEI Achievements Staff02 weeks 3 days ago
Blog entrySCP24: African Group submits revised proposal for a WIPO work program on Patents and Health thiru02 weeks 6 days ago
Blog entrySCP24: KEI statement on Patents and Health thiru03 weeks 3 days ago
PageBackground FAQ on Glivec (imatinib) compulsory license in Colombia Zack Struver03 weeks 3 days ago
Blog entryApril 28, 2016 letter regarding US Senate Finance threats over compulsory license on Novartis cancer drug patents KEI Staff03 weeks 3 days ago
PageWIPO SCCR 32 - links to KEI's reports from the meeting Manon Ress03 weeks 3 days ago
PageNews reports on Senator Hatch pressure over Colombia compulsory license on Novartis drug James Love03 weeks 3 days ago
Blog entryBriefing Call on National Institutes of Health (NIH) patent policies, 29 June 2016, 11:00 A.M. (EST) Zack Struver03 weeks 3 days ago
Blog entrySCP24: KEI statement on exceptions and limitations to patent rights thiru03 weeks 3 days ago
Blog entryStanding Committee on the Law of Patents (SCP) - GRULAC proposal - Revision of 1979 WIPO Model Law for Developing Countries thiru03 weeks 4 days ago
Blog entryColombia Issues Public Interest Declaration To Lower Price of Glivec KEI Staff04 weeks 1 day ago
Blog entryHuman Rights Council heats up during informal talks on the primacy of human rights over international trade and IP regimes thiru04 weeks 1 day ago
Blog entryS. Ward Casscells, Pentagon Medical Chief, Praised Army Role in Xtandi Development Zack Struver04 weeks 3 days ago
Blog entryNIH to taxpayers — we don't care about high prices in US for Xtandi. KEI Staff04 weeks 4 days ago